Design of the FRAIL-AF trail: safety of switching from VKA to DOAC in frail elderly with atrial fibrillation
ISTH Academy, Linda Joosten, 264339
An intracardiac thrombus Associated With Antithrombin Deficiency with a Novel Mutation c.1063T>G in SERPINC1
ISTH Academy, Larfi Yacine, 264359
Cardiovascular diseases and use of antithrombotic agents in patients with end-stage renal disease on hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in hemoDIalysis patients (VIVALDI)
ISTH Academy, Oliver Königsbrügge, 264360
Regulation of Smooth Muscle Cell Phenotype and Neointima Formation by Endothelial Cell- Secreted MicroRNA-21
ISTH Academy, Mao Luo, 264361
Assessment of single-factor deficiency sensitivity of three APTT reagents
ISTH Academy, Claire Martin, 264376
Toll-like receptor 9 activation robustly enhances germinal center and inhibitor formation in response to factor VIII
ISTH Academy, Radoslaw Kaczmarek, 264377
The Calibrated Automated Thrombinography for hemophilia treatment monitoring
ISTH Academy, Natalya Silina, 264378
Comparison of factor VIII half-life as determined using two web-accessible population-based pharmacokinetic applications
ISTH Academy, Jerome Teitel, 264379
Increased platelet contribution to clot strength in cirrhotic patients with non-malignant recent portal vein thrombosis
ISTH Academy, Ecaterina Scarlatescu, 264393
ERK activation was associated with transfusion-related acute lung injury in C-reactive protein-enhanced antibody-mediated murine model of transfusion-related acute lung injury
ISTH Academy, Chih-Chun Chang, 264394
Haemostatic Profiles and Hepatic Dysfunction in Fontan Patients
ISTH Academy, Vera Ignjatovic, 264395
Effects of acute liver failure of Yellow Fever infection on haemostasis assessed by thromboelastometry
ISTH Academy, Letícia Lemos Jardim, 264396
Data interpretation of the ETP-based APC resistance assay and the concept of nAPCsr10, an improved nAPCsr
ISTH Academy, Laure Morimont, 264410
Detection of direct intramembrane interaction between the endothelial protein C receptor and thrombomodulin
ISTH Academy, Ingmar Schoen, 264411
Endothelial Protein C Receptor (EPCR) Levels and EPCR Gene A3 Haplotype in Patients with Sickle Cell Anemia
ISTH Academy, ANIL Tombak, 264412
Understanding the mechanisms of Acquired Protein S Deficiency in Sickle Cell Disease
ISTH Academy, Morayma Reyes-Gil, 264413
Effect of catechins on blood coagulation and on various proteins related to the regulation of blood coagulation which are produced in HepG2 Cells
ISTH Academy, Tatsuya Hayashi, 264428
Defective Zn2+ homeostasis in mouse and human platelets with α- and δ-storage pool disorders
ISTH Academy, Elmina Mammadova-Bach, 264429
Heme induces expression and activation of hematopoietic tissue factor via TLR4 and PDIA3-dependent signaling pathways
ISTH Academy, Bidossessi Wilfried Hounkpe, 264431
Crosslinking of Poly(vinyl) Alcohol Hydrogels Determines Material Thrombogenicity
ISTH Academy, Novella Bates, 264432
Potential role of high-sensitive troponin T in identification of patients with pulmonary embolism (PE) who may be treated safely at home?
ISTH Academy, Stephan Vincent Hendriks, 264448
Coagulation activation in Sickle cell Disease and the effect of Hydroxyurea
ISTH Academy, Munira Borhany, 264449
Immuno-Magnetic Separation allows Antigen-specific extraction of Microvesicle subsets for measurement of TF-dependent procoagulant activity. A proof of concept using pleural fluids containing tumor-derived vesicles
ISTH Academy, Romaric Lacroix, 264450
Global coagulation assays in patients with multiple myeloma and monoclonal gammopathy of unknown significance
ISTH Academy, Rowena Brook, 264451
No change in coagulation factor levels after knee arthroscopy
ISTH Academy, Carolina Eveline Touw, 264466
Integrated GWAS and Gene Expression Data Identifies ORM1 as Potential Regulator of Plasma Cell-free DNA Levels in Families of the GAIT2 Project
ISTH Academy, José Manuel Soria, 264467
Effects of veno-venous extracorporeal membrane oxygenation on coagulation factors- a prospective observational study
ISTH Academy, Deepa Jayakody Arachchillage, 264468
ISTH Academy, Kristen Carter, 264483
Thrombin generation and endothelial dysfunction in patients with systemic sclerosis
ISTH Academy, Jerzy Dropinski, 264484
Assessment of Factor IX Padua activity with a one-stage clotting method and with FXIa- and tissue factor/FVIIa-based chromogenic methods
ISTH Academy, Steffen Rosen, 264485
Comparison of one stage APTT FVIII assay and chromogenic factor (F) VIII assays in patients with severe Haemophilia A, receiving FVIII treatment products
ISTH Academy, Anne Riddell, 264500
Quantitative and qualitative differences exist between APTT reagents in clot waveform analysis in haemophilic plasma spiked with normal plasma and rFVIII products
ISTH Academy, Geoff Kershaw, 264502
Assays performed on samples containing emicizumab - data from a multicentre study of UK NEQAS Blood Coagulation (BC) laboratories
ISTH Academy, Ian Jennings, 264503
Phenotypic Variability in Antiplatelet and Anticoagulant Therapy in African Americans: An ACCOuNT Consortium Study
ISTH Academy, Minoli Perera, 264517
ISTH Academy, Mirta Del Valle Arias, 264518
The Total Thrombus Formation (T-TAS) Platelet Assay, a novel point-of-care test that uses arterial shear stress evaluating antiplatelet therapy
ISTH Academy, kailiang zheng, 264519
A multimodal approach using tranexamic acid plus fibrinogen compensates low levels of thrombin generation following PCC therapy in a polytrauma model
ISTH Academy, Oliver Grottke, 264537
Streptokinase and staphylokinase: mechanisms underlying the differences in their thrombolytic and fibrinogenolytic effects
ISTH Academy, Roza Aisina, 264539
Interaction of cationic and anionic of polyamidoamine dendrimers with plasminogen: influence on the structure and activation of zymogen by streptokinase
ISTH Academy, Liliya Mukhametova, 264540
Peptides derived from basement membrane hydrolysis by snake venom metalloproteinases contribute to the vascular effects of viper venoms
ISTH Academy, Ana M. Moura-da-Silva, 264558
Differences in the hemostatic disturbances in snakebite patients and eventual role of individual snake venom composition
ISTH Academy, Ana M. Moura-da-Silva, 264559
Acquired FXIII inhibitor: patient characteristics and treatment outcome, a case series
ISTH Academy, Sheng-Chieh Chou, 264560
Combination of cyclophosphamide and corticosteroids therapy facilitate remission in acquired hemophilia A patients with high titers of inhibitors: A single center experience in China
ISTH Academy, Naifang Ye, 264574
Three successful cases of AHA patients presenting severe cardiovascular diseases treated with susoctocog-alfa (rpFVIII): a single centre experience
ISTH Academy, Ezio Zanon, 264576
Acquired Hemophilia A with an exorbitant inhibitor and venous thrombosis: successfull treatment with recombinant porcine FVIII plus recombinant FVIIa and immediate anti-CD20 therapy
ISTH Academy, Wolfgang Korte, 264577
Long-term safety of N8-GP (turoctocog alfa pegol) prophylaxis in patients with severe haemophilia A
ISTH Academy, Nicola J Curry, 264591
Non-adherence to treatment may have a direct relationship to lower bleeding rate in hemophilia A (APT Project)
ISTH Academy, Ricardo Camelo, 264592
Treatment Patterns and Outcomes in Persons with Hemophilia A (PwHA): Analysis from the CHOICE Survey in the United States
ISTH Academy, Anisha M. Patel, 264594
Haemostatic therapy for insertion of central venous access devices in severe haemophilia A and B - Melbourne paediatric protocol
ISTH Academy, Sally Campbell, 264608
Predictors of bleeding in severe Haemophilia A
ISTH Academy, Samuel Sarmiento Doncel, 264609
Incidence and Prevalence of Diagnosed and Undiagnosed Hemophilia A and Hemophilia B in Select Countries
ISTH Academy, Emily S. Brouwer, 264610
Comparing Qualitative and Quantitative Data on BAY 94-9027, a New Extended Half-Life Recombinant Factor VIII for the Treatment of Hemophilia A: A Mixed- Method Research Approach.
ISTH Academy, Emilio Musi, 264624
Review of a Port-A-Cath Training Programme for Caregivers in a Paediatric Haemophilia Treatment Centre
ISTH Academy, Chiew Ying Lim, 264625
Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa) in Spain
ISTH Academy, Santiago Bonanad, 264626
Prediction of anti-FVIII inhibitor persistence by anti-FVIII IgG subclasses in patients with severe hemophilia a in the SIPPET cohort study
ISTH Academy, Roberta Palla, 264641
Bone Health In Hemophilic Arthropathy- A Systematic Study from Eastern India
ISTH Academy, PRAKAS Mandal, 264642
Long-term efficacy and safety of recombinant factor IX fusion protein (rIX-FP) in previously treated patients with hemophilia B: Results from a phase 3b extension study
ISTH Academy, Maria Elisa Mancuso, 264643
Comorbidity and transfusion transmitted infections in patients with severe haemophilia: Report from Taiwan Society of Thrombosis and Hemostasis registry
ISTH Academy, Jiaan-Der Wang, 264658
Structure, mechanical and lytic stability of fibrin and plasma coagulum generated by staphylocoagulase from Staphylococcus aureus
ISTH Academy, Craig Thelwell, 264659
Systemic Antifibrinolytic Agents for Hemoptysis Management in Adults with Cystic Fibrosis
ISTH Academy, Jean Connors, 264662
Efficacy of Three Factor Prothrombin Complex in Achieving Haemostasis in Patients with Major Bleeding on Anti-Coagulation - Retrospective Single Centre Study
ISTH Academy, Usha Chandra Sekaran, 264677
GPVI shedding contributes to platelet dysfunction in trauma-induced coagulopathy
ISTH Academy, Samantha Montague, 264678
Efficacy and safety of a 4-factor prothrombin complex concentrate for management of direct Xa inhibitor-induced major bleeding
ISTH Academy, Paul P Dobesh, 264679
Endothelial dysfunction, oxidative stress and activation of Rho A/Rho kinase pathway in major depressive disorder
ISTH Academy, Claudia Saez, 264694
Molecules derived from procoagulant lipocalin (Lopap) as potential hits on blood coagulation, cytoprotection and tissue remodeling
ISTH Academy, Ana Chudzinski-Tavassi, 264695
Decreased Thrombin Generation Potential is Associated with Increased Thrombin Generation Markers in Sepsis Associated Coagulopathy
ISTH Academy, Fakiha Siddiqui, 264696
Non-coding RNA miR-365a-3p Suppresses Tissue Factor Levels and Decreases Thrombin Generation
ISTH Academy, Jiayin Tian, 264711
Developing a novel stem cell and gene therapy system based on resveratrol-induced HSP70 promoter-regulated VEGFA expression
ISTH Academy, KowitYu Chong, 264712
Prolonged therapeutic effects of adipose-derived stem cells via the photoactivation after ischemic injury
ISTH Academy, Jianbo Wu, 264713
All-trans retinoic acid (ATRA) impairs platelet function and thrombus formation and inhibits protein kinase C βI and δ phosphorylation
ISTH Academy, Jianlin Qiao, 264727
The mammalian target of rapamycin controls platelet integrin activation, aggregation, and ischemic stroke
ISTH Academy, Robert Campbell, 264728
Lenalidomide and dexamethasone enhanced platelet activation and in vitro thrombus formation under arterial flow
ISTH Academy, Fehaid Alanazi, 264729
Potential for ice recrystallisation inhibitors to improve cryopreserved platelet recovery and quality
ISTH Academy, Lauren Waters, 264745
The role of NMDA receptors in platelet specific hemostasis
ISTH Academy, Lili Donner, 264746
Elevated soluble GPVI levels in patients with symptomatic aortic stenosis and left ventricular remodelling
ISTH Academy, Cecile Oury, 264747
Ceruloplasmin reduces the ability of thrombin to cause platelet aggregation
ISTH Academy, Irina Gorudko, 264762
Effect of monomeric myeloperoxidase on platelet function
ISTH Academy, Irina Gorudko, 264763
Platelets are associated with reduced survival in lung adenocarcinoma patients and promote metastatic dissemination in murine models
ISTH Academy, Stephanie R. Hyslop, 264764
ISTH Academy, Michael Dockal, 264780
Recombinant ADAMTS13 (TAK-755/SHP655) can override the inhibitory effect of free hemoglobin on von Willebrand factor (VWF) multimer cleavage in vitro
ISTH Academy, Werner Hoellriegl, 264781
Dose-dependent effects of recombinant ADAMTS13 (TAK-755/SHP655) on recovery in a humanized mouse model of sickle cell disease
ISTH Academy, Werner Hoellriegl, 264782
Red blood cells transfusion can improve hemostatic dysfunction of Heyde Syndrome
ISTH Academy, Ayaka Kakiwaki, 264797
Acquired thrombotic thrombocytopenic purpura occurring in advanced age: impact of a delayed onset on disease expression
ISTH Academy, Andrea Artoni, 264798
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
ISTH Academy, Ilaria Mancini, 264799
Initial thrombus above or below popliteal fossa is more predictive than residual thrombosis for postthrombotic syndrome after episode of deep venous thrombosis - RIETE experience with 1183 patients
ISTH Academy, Marijan Bosevski, 264814
Sex-specific Differences in the Clinical Presentation, Surgical Complications, and Course of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Insights from the European CTEPH Registry
ISTH Academy, Stefano Barco, 264815
Post-thrombotic syndrome, some unexpected results
ISTH Academy, Mohamed Habib Houman, 264816
Trends in referrals to an ambulatory deep vein thrombosis service over ten years at Cambridge University NHS Foundation Trust
ISTH Academy, Will Thomas, 264831
Features of thrombosis of the vena cava on a series of 1045 vein thrombosis
ISTH Academy, Mohamed Habib Houman, 264832
MRDTI Can Distinguish Between Old and New Thrombosis in the Abdominal Aorta: A Case Report
ISTH Academy, Lisette F. van Dam, 264833
ISTH Academy, Milan Kostal, 264847
Cerebral venous thrombosis: a study about 1045 cases
ISTH Academy, Mohamed Habib Houman, 264848
Recurrences after Splanchnic Vein Thrombosis: Risk Factors and Efficacy of Vitamin K-Antagonists in a Retrospective Monocenter Cohort of 207 Patients
ISTH Academy, Valerio De Stefano, 264849
Safety and Efficacy of Full Dose Dabigatran in the Treatment of Deep Vein Thrombosis in a Very Young Adolescent
ISTH Academy, Franco Piovella, 264864
Direct Oral Anticoagulant Laboratory Assay Assessment at a Large Academic Medical Center
ISTH Academy, Sharonlin Bhardwaj, 264865
The CTPA Epidemic?
ISTH Academy, Sarah Kelliher, 264866
Thrombin generationin Chinese pregnant women and the effect of insulin useon thrombin generation in GDM patients
ISTH Academy, Xiaowei Qi, 264887
Changes in the thrombocytic link of the hemostasis system in pregnant women with preeclampsia
ISTH Academy, Bakhodir Kurbanov, 264888
Transfusions during pregnancy or postpartum in 3 Italian Tertiary level Obstetrics Departments: A retrospective analysis
ISTH Academy, Elvira Grandone, 264890
Inherited thrombophilia in infertility patients in Macedonia
ISTH Academy, Elena Petkovikj, 264906

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings